Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

MYC plus class IIa HDAC inhibition drives mitochondrial dysfunction in non-small cell lung cancer

Cell Reports(2025)10.1016/j.celrep.2025.115722Source: DataRank Database

MYC plus class IIa HDAC inhibition drives mitochondrial dysfunction in non-small cell lung cancer is a research paper published in Cell Reports (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.41)OA: goldTopics (40)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Ying-Yu Chen,Jennie J. Cao ORCID,Julia An ORCID,Ray-Whay Chiu Yen,John D. Outen

Live enrichment

PubMed:40392656 OpenAlex:https://openalex.org/W4410504411

National Cancer Institute

Grant: P30CA006973

National Cancer Institute

Grant: P50CA254897

Entertainment Industry Foundation

Van Andel Institute

Kwanjeong Educational Foundation

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

National Institutes of Health

FWCI

0.41

Citation Percentile

0.6%

Citation Trend

2026

goldLicense: cc-by

journalhttps://www.cell.com/action/showPdf?pii=S2211124725004930

publisherhttps://www.cell.com/action/showPdf?pii=S2211124725004930

publisherhttps://api.elsevier.com/content/article/PII:S2211124725004930?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124725004930?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.celrep.2025.115722

Fields of Study

Histone Deacetylase Inhibitors ResearchProtein Degradation and InhibitorsEpigenetics and DNA Methylation

MeSH Terms

AnimalsCarcinoma, Non-Small-Cell LungHistone DeacetylasesHumansLung NeoplasmsMitochondriaProto-Oncogene Proteins c-mycReactive Oxygen SpeciesXenograft Model Antitumor AssaysCell Line, TumorMiceHistone Deacetylase Inhibitors

Keywords

Cancer researchHistone deacetylaseBiologyTranscriptomeCancerLung cancerIn vivoMitochondrionHistone deacetylase 5Viability assayHistoneCell cultureCell biologyMedicineBiochemistryGeneticsGene expressionGeneInternal medicineMitochondriaMYCNon-small lung cancerClass Iia HdacOxidative StessCp: Cancer

Sustainable Development Goals

SDG 0: Good health and well-being